Hong-Shong Chang

Title: Innovations of Hong-Shong Chang in Inflammatory Disease Treatment

Introduction

Hong-Shong Chang is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of medical science, particularly in the treatment of inflammatory diseases. His innovative approach combines nanotechnology with pharmacology to develop effective therapeutic methods.

Latest Patents

Hong-Shong Chang holds a patent for a method for treating inflammatory diseases. This patent discloses a method that includes administering a therapeutically effective amount of a dihydrolipoic acid (DHLA) coated gold nanocluster, which ranges from about 0.1 to 20 nm in diameter. The patent also describes a method for reducing the expression of a pro-inflammatory molecule in cultured cells by using the DHLA coated gold nanocluster. Furthermore, it includes a pharmaceutical composition that utilizes this nanocluster, proving useful for treating inflammatory diseases in subjects.

Career Highlights

Throughout his career, Hong-Shong Chang has worked with reputable institutions such as Mackay Memorial Hospital and Goldred Nanobiotech Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the development of innovative treatments.

Collaborations

Hong-Shong Chang has collaborated with notable colleagues, including Hsueh-Hsiao Wang and Hung-I Yeh. These collaborations have likely enriched his research and expanded the impact of his inventions.

Conclusion

Hong-Shong Chang's innovative methods for treating inflammatory diseases highlight the intersection of nanotechnology and medicine. His contributions are paving the way for new therapeutic options in the medical field.